Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 54 Lung Neoplasms 46 Neoplasm Metastasis 36 Carcinoma, Non-Small-Cell Lung 36 Multiple Myeloma 26 Breast Neoplasms 26 Glioma 23 Carcinoma, Renal Cell 22 Pancreatic Neoplasms 21 Melanoma 21 Glioblastoma 21 Lymphoma, Large B-Cell, Diffuse 20 Squamous Cell Carcinoma of Head and Neck 19 Ovarian Neoplasms 19 Urinary Bladder Neoplasms 18 Lymphoma 18 Colorectal Neoplasms 18 Triple Negative Breast Neoplasms 15 Oropharyngeal Neoplasms 15 Mouth Neoplasms 15 Brain Neoplasms 15 Fallopian Tube Neoplasms 13 Carcinoma, Hepatocellular 13 Carcinoma 13 Laryngeal Neoplasms 12 Astrocytoma 12 Lymphoma, Follicular 11 Leukemia, Myeloid, Acute 11 Sarcoma 10 Neuroblastoma 10

Interventions

Specimen Handling 6 Tamoxifen 4 ruxolitinib 1 pembrolizumab 1 exemestane 1 Watchful Waiting 1 Surveys and Questionnaires 1 Starch 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Radiation 1 Protons 1 Proton Therapy 1 Omacor 1 Observation 1 Methods 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Laser Therapy 1 Interviews as Topic 1 Hypnosis, Anesthetic 1 Genotype 1 Educational Status 1 Early Intervention, Educational 1 Decision Support Techniques 1 Counseling 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Magnetic Resonance Spectroscopy × 90 days × Clear all

NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡